MedTrace Logo

First-day High Dose Vitamin C, E in Severe Birth Asphyxia

NCT01743742 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2022-07-07

No results posted yet for this study

Summary

To study the role of first-day high dose oral vitamin C and first-day single high dose oral vitamin E in hypoxic-ischemic encephalopathy in newborns, in the reduction of morbidity and adverse neurodevelopmental sequelae.

Conditions

  • Birth Asphyxia

Interventions

DRUG

Vitamin E, Vitamin C

Sponsors & Collaborators

  • Sir Takhtasinhji General Hospital

    lead OTHER_GOV

Principal Investigators

  • Jayendra R Gohil, MD · Professor Pediatrics, Govt Medical College, Bhavnagar, Gujarat, India

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Minute
Max Age
6 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-09-30
Completion
2013-10-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01743742 on ClinicalTrials.gov